Angiotensin 1-9 and 1-7 Release in Human Heart: Role of Cathepsin A

No abstract is available for this paper.

• Publication year

  2002

• Venue

  HYPERTENSION

• Publication date

  2002-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.HYP.0000017283.67962.02PMID 12019279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of Bradykinin by Peptidases in Health and Disease

  2007cited by this paper
• Mast cell carboxypeptidase

  2004cited by this paper
• Progression of chronic renal disease.

  2003cited by this paper
• Vasopeptidase inhibitors: an emerging class of cardiovascular drugs.

  2001cited by this paper
• Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice

  2001cited by this paper
• Vascular gp91(phox): beyond the endothelium.

  2000cited by this paper
• Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.

  2000cited by this paper
• Replacement of the Transmembrane Anchor in Angiotensin I-converting Enzyme (ACE) with a Glycosylphosphatidylinositol Tail Affects Activation of the B2 Bradykinin Receptor by ACE Inhibitors*

  2000cited by this paper
• A Human Homolog of Angiotensin-converting Enzyme

  2000cited by this paper
• Beyond the Endothelium

  2000cited by this paper
• Angiotensin-(1-7): an update.

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

  2000cited by this paper
• Effects of the N-terminal sequence of ACE on the properties of its C-domain.

  2000cited by this paper
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000cited by this paper
• Potentiation of Bradykinin Actions by ACE Inhibitors.

  1999cited by this paper
• Enhancement of bradykinin and resensitization of its B2 receptor.

  1999cited by this paper
• Cathepsin A/protective protein: an unusual lysosomal multifunctional protein

  1999cited by this paper
• Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system.

  1998cited by this paper
• N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

  1998cited by this paper
• Handbook of proteolytic enzymes

  1998cited by this paper
• The Kinin System

  1997cited by this paper
• Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.

  1997cited by this paper
• Mechanical transduction of nitric oxide synthesis in the beating heart.

  1997cited by this paper
• Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition in type I diabetic nephropathy.

  1996cited by this paper
• Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.

  1995cited by this paper
• Human lysosomal beta-galactosidase-cathepsin A complex: definition of the beta-galactosidase-binding interface on cathepsin A.

  1995cited by this paper
• Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69).

  1995cited by this paper
• Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograft.

  1995cited by this paper
• Lysosomal Protective Protein/Cathepsin A

  1995cited by this paper
• Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages.

  1995cited by this paper
• A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

  1993cited by this paper
• Inactivation of endothelin-1 by an enzyme of the vascular endothelial cells.

  1993cited by this paper
• Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

  1993cited by this paper
• Inactivation of endothelin I by deamidase (lysosomal protective protein).

  1992cited by this paper
• In Vivo Metabolism of Angiotensin I by Neutral Endopeptidase (EC 3.4.24.11) in Spontaneously Hypertensive Rats

  1992cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• Metabolism of substance P and bradykinin by human neutrophils.

  1991cited by this paper
• A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein".

  1990cited by this paper
• Chapter 12. Small Molecular Protease Inhibitors and Their Biological Effects

  1990cited by this paper
• Human mast cell carboxypeptidase.

  1990cited by this paper
• Human mast cell carboxypeptidase. Purification and characterization.

  1989cited by this paper
• [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II.

  1988cited by this paper
• Conversion of angiotensin I to angiotensin II by cathepsin A isoenzymes of porcine kidney.

  1988cited by this paper
• Subcellular localization in rat brain of angiotensin-related carboxypeptidase activity distinct from converting enzyme.

  1988cited by this paper
• Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.

  1986cited by this paper
• A human platelet angiotensin I-processing system. Identification of components and inhibition of angiotensin-converting enzyme by product.

  1985cited by this paper
• Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides.

  1983cited by this paper
• Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

  1982cited by this paper
• Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure

  1978cited by this paper
• Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney.

  1978cited by this paper
• Stabilization of pig kidney cathepsin A by sucrose and chloride ion, and inhibition of the enzyme activity by diisopropyl fluorophosphate and sulfhydryl reagents.

  1974cited by this paper
• Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).

  1971cited by this paper
• An enzyme in microsomal fraction of kidney that inactivates bradykinin.

  1967cited by this paper

• Upregulation of angiotensin-(1–7) formation in human podocytes – enzyme activity assay upon fluid flow shear stress

  2026cites this paper
• It’s a Trap!—Potential of Cathepsins in NET Formation

  2025cites this paper
• Alternative Renin-Angiotensin System

  2024cites this paper
• Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis

  2024cites this paper
• Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

  2024cites this paper
• The RAAS Goodfellas in Cardiovascular System

  2023cites this paper
• Gene expression QTL mapping in stimulated iPSC-derived macrophages provides insights into common complex diseases

  2023cites this paper
• Multi-faceted roles of cathepsins in ischemia reperfusion injury (Review)

  2022cites this paper
• Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic

  2022cites this paper
• The neurovascular unit in leukodystrophies: towards solving the puzzle

  2022cites this paper
• An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection

  2022cites this paper
• Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity

  2021cites this paper
• Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19

  2021cites this paper
• Pathology of the neurovascular unit in leukodystrophies

  2021cites this paper
• Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation

  2021cites this paper
• Local ocular renin–angiotensin–aldosterone system: any connection with intraocular pressure? A comprehensive review

  2020cites this paper
• Development of a novel nanoflow liquid chromatography-parallel reaction monitoring mass spectrometry-based method for quantification of angiotensin peptides in HUVEC cultures

  2020cites this paper
• ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review.

  2020cites this paper
• Cathepsin A contributes to left ventricular remodeling by degrading extracellular superoxide dismutase in mice

  2020influential citation
• An update on ACE2 amplification and its therapeutic potential

  2020cites this paper
• Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.

  2019cites this paper
• The effects of certain gasotransmitters inhibition on homocysteine acutely induced changes on rat cardiac acetylcholinesterase activity

  2019cites this paper
• Renal Modulation

  2019cites this paper
• Renin-angiotensin and kallikrein-kinin systems in diabetic retinopathy

  2019cites this paper
• The opposite effects of angiotensin 1-9 and angiotensin 3-7 in prostate epithelial cells.

  2019cites this paper
• Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure

  2019cites this paper
• An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology

  2019cites this paper
• Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease

  2019cites this paper
• The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion

  2018cites this paper
• Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease

  2018cites this paper
• Angiotensin‐(1‐9) reduces cardiovascular and renal inflammation in experimental renin‐independent hypertension

  2018cites this paper
• Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor

  2018cites this paper
• Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry

  2017cites this paper
• The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

  2017cites this paper
• Angiotensin converting enzymes in fish venom

  2017cites this paper
• The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.

  2017cites this paper
• Molecular Cloning, Characterization, and Expression Analysis of Cathepsin A in the Chinese Giant Salamander Andrias davidianus.

  2017cites this paper
• Many Faces of Renin-angiotensin System - Focus on Eye

  2017cites this paper
• Novel Therapies Targeting Cardioprotection and Regeneration.

  2017cites this paper
• Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides

  2016cites this paper
• Altered mitochondrial expression genes in patients receiving right ventricular apical pacing.

  2016cites this paper
• Tolerability, safety, and pharmacokinetics of the novel cathepsin A inhibitor SAR164653 in healthy subjects

  2016cites this paper
• Perindoprilat changes ANG (1-9) production in renal arteries isolated from young spontaneously hypertensive rats after ANG I incubation.

  2016cites this paper
• ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.

  2016cites this paper
• Single- and repeat-dose toxicity of IDX14184, a nucleotide prodrug with antiviral activity for hepatitis C viral infection, in mice, rats, and monkeys

  2016cites this paper
• Angiotensin II control of regional haemodynamics in rats with aortocaval fistula

  2016cites this paper
• Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)

  2016influential citation
• Function of renin angiotensin system on heart failure

  2016cites this paper
• Angiotensins processing activities in the venom and epidermic mucus of Scorpaena plumieri.

  2016cites this paper
• Cardiac ACE2/angiotensin 1–7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy

  2016cites this paper
• Proteomic Profiling of Cardiomyocyte-Specific Cathepsin A Overexpression Links Cathepsin A to the Oxidative Stress Response.

  2016cites this paper
• Perindoprilat Changes ANG (1-9) Production in Renal Arteries Isolated From Young Spontaneously Hypertensive Rats After ANG I Incubation

  2016cites this paper
• Cathepsin A mediates susceptibility to atrial tachyarrhythmia and impairment of atrial emptying function in Zucker diabetic fatty rats.

  2016cites this paper
• Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats.

  2015cites this paper
• ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension

  2015cites this paper
• Angiotensin processing activities in the venom of Thalassophryne nattereri.

  2015cites this paper
• Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors

  2015cites this paper
• Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9).

  2015cites this paper
• eview ovel players in cardioprotection : Insulin like growth factor-1 , ngiotensin-( 1 – 7 ) and angiotensin-( 1 – 9 )

  2015cites this paper
• Ocular renin-angiotensin system with special reference in the anterior part of the eye

  2015cites this paper
• New Components of the Renin-Angiotensin-Aldosterone System andOxidative Stress

  2015cites this paper
• Lysosomal multienzyme complex: pros and cons of working together

  2014cites this paper
• The role of Angiotensin-(1-7) and Angiotensin-(1-9) in vascular remodelling

  2014cites this paper
• Different cross-talk sites between the renin–angiotensin and the kallikrein–kinin systems

  2014cites this paper
• Reply: dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure.

  2014cites this paper
• Angiotensin-(1-7).

  2014cites this paper
• Angiotensin-( 1-7 ) and angiotensin-( 1-9 ) : function in cardiac and vascular remodeling

  2014influential citation
• Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis

  2014cites this paper
• Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.

  2014cites this paper
• Retinal arteriolar diameters and incident hypertension in initially normotensive individuals: a masked hypertension effect?

  2014cites this paper
• Is the renin–angiotensin system actually hypertensive?

  2014cites this paper
• Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system.

  2014cites this paper
• Update on the Renin-Angiotensin System

  2014cites this paper
• STRUCTURAL BIOLOGY AND PHARMACOLOGY OF HUMAN CATHEPSIN A AND NEURAMINIDASE 1

  2014cites this paper
• Serine Carboxypeptidase SCPEP1 and Cathepsin A Play Complementary Roles in Regulation of Vasoconstriction via Inactivation of Endothelin-1

  2014cites this paper
• Reply: retinal arteriolar diameters and incident hypertension in initially normotensive individuals: a masked hypertension effect?

  2014cites this paper
• Proteolytic Activation of Human Cathepsin A

  2014cites this paper
• Angiotensin-(1–9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis

  2014cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Angiotensin-Peptiden

  2013cites this paper
• Lysosomal Carboxypeptidase A

  2013cites this paper
• Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

  2013cites this paper
• Pharmacological potential of exercise and RAS vasoactive peptides for prevention of diseases.

  2013cites this paper
• Experimental studies on new therapeutic approaches in atrial fibrillation

  2013cites this paper
• Proteolytic Processing of Angiotensin-I in Human Blood Plasma

  2013cites this paper
• Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.

  2013cites this paper
• Proteomic characterization of serine hydrolase activity and composition in normal urine

  2013cites this paper
• Inhibition of CatA: an emerging strategy for the treatment of heart failure.

  2013cites this paper
• Molecular Genetics and Metabolism.

  2013cites this paper
• Efeitos da inibição da enzima conversora de angiotensina sobre a doença periodontal induzida experimentalmente em ratos

  2013cites this paper
• The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease

  2012cites this paper
• Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly.

  2012cites this paper
• Novel β-amino acid derivatives as inhibitors of cathepsin A.

  2012cites this paper
• Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 Receptor

  2012cites this paper
• NEW INSIGHTS INTO THE GENERATION OF THE ANGIOTENSIN PEPTIDES

  2012cites this paper
• Carboxypeptidases A1 and A2 from the perfusate of rat mesenteric arterial bed differentially process angiotensin peptides.

  2012cites this paper
• Role of ACE2 in diastolic and systolic heart failure

  2012cites this paper
• Protective Role of the ACE2/Ang-(1–9) Axis in Cardiovascular Remodeling

  2012cites this paper
• Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7).

  2012cites this paper
• Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension

  2011cites this paper
• Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

  2011influential citation